← Back to Clinical Trials
Recruiting NCT07632352

NCT07632352 Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07632352
Status Recruiting
Phase
Sponsor Henan University of Traditional Chinese Medicine
Condition Bronchial Asthma
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2025-04-15
Primary Completion 2026-09-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
AcupunctureStandard Western medicine treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 72 participants in total. It began in 2025-04-15 with a primary completion date of 2026-09-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Based on the bioholographic theory, this study preliminarily explores the clinical efficacy of hand acupuncture in treating acute exacerbation of bronchial asthma and evaluates its immediate anti-asthmatic effect, so as to provide a new therapeutic strategy for the clinical management of bronchial asthma.

Eligibility Criteria

Inclusion Criteria: 1. Patients meeting the Western medicine diagnostic criteria for acute exacerbation of bronchial asthma 2. Aged ≥ 18 years old 3. Voluntarily receive treatment and sign the informed consent form Exclusion Criteria: 1. Those who fail to meet the inclusion criteria 2. Patients suffering from other severe systemic diseases such as diseases of the circulatory system, hematological system and nervous system 3. Pregnant or lactating women 4. Subjects enrolled but not treated per the study protocol 5. Patients who have participated in other clinical trials of medicinal products within 3 months 6. Other circumstances deemed ineligible for enrollment by researchers

Contact & Investigator

Central Contact

Qinmei Yang

✉ yangqinmei840105@126.com

📞 15981845716

Frequently Asked Questions

Who can join the NCT07632352 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Bronchial Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07632352 currently recruiting?

Yes, NCT07632352 is actively recruiting participants. Contact the research team at yangqinmei840105@126.com for enrollment information.

Where is the NCT07632352 trial being conducted?

This trial is being conducted at Zhengzhou, China.

Who is sponsoring the NCT07632352 clinical trial?

NCT07632352 is sponsored by Henan University of Traditional Chinese Medicine. The trial plans to enroll 72 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology